Which antihypertensive agents are safe for an adult patient with coarctation of the aorta?

Antihypertensive Management in Coarctation of the Aorta

Guideline-directed medical therapy (GDMT) using standard antihypertensive agents is recommended for treating hypertension in adults with coarctation of the aorta, with beta-blockers, ACE inhibitors, and angiotensin receptor blockers serving as first-line agents. 1, 2, 3

Primary Recommendation

The 2018 AHA/ACC and 2022 ACC/AHA guidelines explicitly state that GDMT is recommended (Class I recommendation) for treatment of hypertension in patients with coarctation of the aorta. 1, 2 This means that all standard antihypertensive medications used for essential hypertension are safe and appropriate in this population.

Specific Agent Selection

First-Line Agents

• Beta-blockers are particularly effective and well-studied in coarctation patients 3, 4, 5

  • Atenolol has demonstrated efficacy in reducing exercise-induced upper body hypertension after coarctation repair, normalizing systolic blood pressure in 9 of 10 patients without affecting exercise endurance 4
  • Labetalol (combined alpha/beta blocker) is fast, effective, and safe for post-coarctectomy hypertension, with 48% of patients successfully transitioned to oral therapy at discharge 5

• ACE inhibitors are recommended as first-line agents 3

• Angiotensin receptor blockers (ARBs) are recommended as first-line agents 3

Additional Agents

• Thiazide diuretics (hydrochlorothiazide) have been used successfully in combination therapy 6

• Alpha-blockers (prazosin) have been studied in combination regimens 6

Critical Clinical Considerations

Blood Pressure Monitoring Requirements

• Measure BP in both upper extremities AND one lower extremity at every visit (Class I recommendation) 1, 2
• Ambulatory BP monitoring is useful for diagnosis and management (Class IIa recommendation) 1
• Exercise testing to evaluate exercise-induced hypertension may be reasonable in patients who exercise (Class IIb recommendation) 1

Important Caveats

Hypertension persists even after successful repair. Even with excellent surgical or endovascular repair, hypertension remains common and predisposes to myocardial infarction, stroke, and heart failure. 1 At long-term follow-up (mean 5.2 years), 31% of adults still required antihypertensive medication despite successful repair. 7

Exercise-induced hypertension is particularly problematic. Upper body systolic hypertension during exercise is well-documented after coarctation repair, even when resting gradients are normal (≤18 mmHg). 4 Beta-blockers are especially effective for this indication. 4

Treatment Algorithm

1. Confirm diagnosis with upper and lower extremity BP measurements 1, 2

2. Initiate first-line therapy with beta-blocker, ACE inhibitor, or ARB 3

   • Beta-blockers preferred if exercise-induced hypertension is present 4
   • Labetalol particularly useful in acute post-operative setting 5

3. Add second agent if BP not controlled (thiazide diuretic or alternative first-line agent) 6

4. Monitor with ambulatory BP monitoring to capture exercise-induced hypertension 1

5. Lifelong follow-up required regardless of repair status, as cardiovascular risks persist 1, 2

No Contraindicated Agents

There are no specific antihypertensive agents contraindicated in coarctation of the aorta. The guidelines explicitly recommend GDMT, which encompasses all standard antihypertensive classes. 1, 2 The key is aggressive treatment to prevent long-term cardiovascular complications including premature coronary artery disease, stroke, aortic aneurysm, dissection, and heart failure. 3